3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
1406
Neoplasms
1131
Prostatic Neoplasms
746
Lung Neoplasms
622
Colorectal Neoplasms
598
Carcinoma, Non-Small-Cell Lung
571
Carcinoma, Hepatocellular
416
Pancreatic Neoplasms
401
Leukemia, Myeloid, Acute
398
Stomach Neoplasms
356
Multiple Myeloma
327
Brain Neoplasms
313
Ovarian Neoplasms
309
Head and Neck Neoplasms
292
Neoplasm Metastasis
277
Precursor Cell Lymphoblastic Leukemia-Lymphoma
261
Rectal Neoplasms
255
Uterine Cervical Neoplasms
248
Recurrence
248
Melanoma
243
Esophageal Neoplasms
237
Glioblastoma
232
Squamous Cell Carcinoma of Head and Neck
230
Lymphoma
214
Sarcoma
209
Urinary Bladder Neoplasms
194
Colonic Neoplasms
192
Glioma
191
Triple Negative Breast Neoplasms
190
Hematologic Neoplasms
183
Interventions
pembrolizumab
1
binimetinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
OTHER
×
Non-small Cell Carcinoma
×
Clear all
NCT03991819
2025-12-05
BiniPembro
University Health Network, Toronto
Phase 1
Recruiting
40 enrolled